American Portfolios Advisors’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$410 Hold
17
﹤0.01% 3406
2022
Q2
$354 Sell
17
-8
-32% -$249 ﹤0.01% 3421
2022
Q1
$1.13K Sell
25
-83
-77% -$3.45K ﹤0.01% 3343
2021
Q4
$4.72K Hold
108
﹤0.01% 2919
2021
Q3
$8.84K Sell
108
-50
-32% -$4.56K ﹤0.01% 2621
2021
Q2
$17.9K Buy
158
+8
+5% +$804 ﹤0.01% 2272
2021
Q1
$17.4K Buy
150
+44
+42% +$6.88K ﹤0.01% 2139
2020
Q4
$15.7K Buy
+106
New +$12.1K ﹤0.01% 1930
2020
Q1
Sell
-118
Closed -$10.1K 2929
2019
Q4
$10.1K Buy
118
+43
+57% +$4.03K ﹤0.01% 1992
2019
Q3
$4.69K Sell
75
-6
-7% -$505 ﹤0.01% 2225
2019
Q2
$10.2K Hold
81
﹤0.01% 1891
2019
Q1
$19.3K Hold
81
﹤0.01% 1594
2018
Q4
$18.7K Sell
81
-10
-11% -$2.52K ﹤0.01% 1402
2018
Q3
$25K Sell
91
-20
-18% -$6.01K ﹤0.01% 1405
2018
Q2
$37.5K Buy
+111
New +$36.5K 0.01% 1188
2018
Q1
Hold
0
2284
2017
Q4
Hold
0
2239

Other funds holding VIVS

American Portfolios Advisors's VIVS Position: Q3 2022 in Review

American Portfolios Advisors held its VivoSim Labs (VIVS) position steady in Q3 2022 at 17 shares worth $410. The position accounts for ﹤0.01% of the portfolio, ranked #3406.

American Portfolios Advisors first reported a position in VIVS in Q2 2018 and has held it in 15 quarters since. The position peaked at $37.5K in Q2 2018. 39 funds tracked by Wall St. Rank hold VIVS as of Q3 2022.

  • American Portfolios Advisors held 17 shares of VivoSim Labs worth $410 as of Q3 2022.
  • American Portfolios Advisors left its VivoSim Labs share count unchanged in Q3 2022.
  • VivoSim Labs made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3406 holding.
  • American Portfolios Advisors first reported a position in VivoSim Labs in Q2 2018 and has held it in 15 quarters since.
  • American Portfolios Advisors's VivoSim Labs position peaked at $37.5K in Q2 2018.
  • 39 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.